secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quince Therapeutics, Inc. (QNCX)
CIK:        0001662774
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0001193125-24-001482
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Quince Therapeutics regains Nasdaq minimum bid price compliance
---------------------------------------------------------------

- Nasdaq notified Quince on Dec 4, 2023 of non-compliance due to bid price below $1.00 for 30 consecutive days.
- On Dec 29, 2023, Nasdaq confirmed compliance after closing bid price ≥ $1.00 for 13 consecutive business days.
- The matter is closed; Quince remains listed on the Nasdaq Global Select Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662774/000119312524001482/0001193125-24-001482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662774/000119312524001482/d641060d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-001482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer